← Open Payments lookup

JOHN COOK: Open Payments

NPI 1578030813 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,934 in 17 payments from 13 companies in 2025. Trend: 2023 $1,987 · 2024 $691 · 2025 $1,934

Food & beverage: $1,934
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$340
Janssen Pharmaceuticals, Inc3$322
Abbott Laboratories1$146
ABIOMED1$126
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$125
Otsuka America Pharmaceutical, Inc.1$124
Corcept Therapeutics1$123
Gilead Sciences, Inc.1$122
LivaNova USA, Inc.1$112
E.R. Squibb & Sons, L.L.C.1$108

Products named: SPRAVATO, INVEGA, PROCLAIM, CAPLYTA, ABILIFY MAINTENA, Korlym, INGREZZA, Livdelzi.

Industry payments across TX — which companies pay providers there.